Stay updated on FT-2102 in IDH1+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1+ AML/MDS Clinical Trial page.

Latest updates to the FT-2102 in IDH1+ AML/MDS Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry for v3.3.2 was added and the older v3.2.0 entry removed from the history, a minor backend version update with no visible user-facing changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding and operating status notice from the page header; the study record history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check74 days agoChange DetectedUpdates appear only in the Record History section, reflecting new version entries and timestamps rather than changes to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check103 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference10%

Stay in the know with updates to FT-2102 in IDH1+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1+ AML/MDS Clinical Trial page.